Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk

Background The role of inflammation in coronary artery disease (CAD) pathogenesis is well recognized. Moreover, smoking inhalation increases the activity of inflammatory mediators through an increase in leukotriene synthesis essential in atherosclerosis pathogenesis. Aim The aim of this study is to...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Merhi, Mahmoud (author)
مؤلفون آخرون: Demirdjian, Sally (author), Hariri, Essa (author), Sabbah, Nada (author), Youhanna, Sonia (author), Ghassibe-Sabbagh, Michella (author), Naoum, Joseph (author), Haber, Marc (author), Kanbar, Roy (author), Zalloua, Pierre (author), Khazen, Georges (author)
التنسيق: article
منشور في: 2015
الوصول للمادة أونلاين:http://hdl.handle.net/10725/3347
http://dx.doi.org/10.1007/s00011-015-0821-1
http://link.springer.com/article/10.1007/s00011-015-0821-1
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513460988018688
author Merhi, Mahmoud
author2 Demirdjian, Sally
Hariri, Essa
Sabbah, Nada
Youhanna, Sonia
Ghassibe-Sabbagh, Michella
Naoum, Joseph
Haber, Marc
Kanbar, Roy
Zalloua, Pierre
Khazen, Georges
author2_role author
author
author
author
author
author
author
author
author
author
author_facet Merhi, Mahmoud
Demirdjian, Sally
Hariri, Essa
Sabbah, Nada
Youhanna, Sonia
Ghassibe-Sabbagh, Michella
Naoum, Joseph
Haber, Marc
Kanbar, Roy
Zalloua, Pierre
Khazen, Georges
author_role author
dc.creator.none.fl_str_mv Merhi, Mahmoud
Demirdjian, Sally
Hariri, Essa
Sabbah, Nada
Youhanna, Sonia
Ghassibe-Sabbagh, Michella
Naoum, Joseph
Haber, Marc
Kanbar, Roy
Zalloua, Pierre
Khazen, Georges
dc.date.none.fl_str_mv 2015
2016-03-17T09:19:37Z
2016-03-17T09:19:37Z
2016-03-17
dc.identifier.none.fl_str_mv 1023-3830
http://hdl.handle.net/10725/3347
http://dx.doi.org/10.1007/s00011-015-0821-1
Merhi, M., Demirdjian, S., Hariri, E., Sabbah, N., Youhanna, S., Ghassibe-Sabbagh, M., ... & Chammas, E. (2015). Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk. Inflammation Research, 64(6), 415-422.
http://link.springer.com/article/10.1007/s00011-015-0821-1
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Inflammation Research
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Background The role of inflammation in coronary artery disease (CAD) pathogenesis is well recognized. Moreover, smoking inhalation increases the activity of inflammatory mediators through an increase in leukotriene synthesis essential in atherosclerosis pathogenesis. Aim The aim of this study is to investigate the effect of “selected” genetic variants within the leukotriene (LT) pathway and other variants on the development of CAD. Methods CAD was detected by cardiac catheterization. Logistic regression was performed to investigate the association of smoking and selected susceptibility variants in the LT pathway including ALOX5AP, LTA4H, LTC4S, PON1, and LTA as well as CYP1A1 on CAD risk while controlling for age, gender, BMI, family history, diabetes, hyperlipidemia, and hypertension. Results rs4769874 (ALOX5AP), rs854560 (PON1), and rs4646903 (CYP1A1 MspI polymorphism) are significantly associated with an increased risk of CAD with respective odds ratios of 1.53703, 1.67710, and 1.35520; the genetic variant rs9579646 (ALOX5AP) is significantly associated with a decreased risk of CAD (OR 0.76163). Moreover, a significant smoking-gene interaction is determined with CYP1A1 MspI polymorphism rs4646903 and is associated with a decreased risk of CAD in current smokers (OR 0.52137). Conclusion This study provides further evidence that genetic variation of the LT pathway, PON1, and CYP1A1 can modulate the atherogenic processes and eventually increase the risk of CAD in our study population. Moreover, it also shows the effect of smoking-gene interaction on CAD risk, where the CYP1A1 MspI polymorphism revealed a decreased risk in current smokers.
eu_rights_str_mv openAccess
format article
id LAURepo_fdfd13eeb38c4c32c3e7e25e24af34ef
identifier_str_mv 1023-3830
Merhi, M., Demirdjian, S., Hariri, E., Sabbah, N., Youhanna, S., Ghassibe-Sabbagh, M., ... & Chammas, E. (2015). Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk. Inflammation Research, 64(6), 415-422.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/3347
publishDate 2015
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease riskMerhi, MahmoudDemirdjian, SallyHariri, EssaSabbah, NadaYouhanna, SoniaGhassibe-Sabbagh, MichellaNaoum, JosephHaber, MarcKanbar, RoyZalloua, PierreKhazen, GeorgesBackground The role of inflammation in coronary artery disease (CAD) pathogenesis is well recognized. Moreover, smoking inhalation increases the activity of inflammatory mediators through an increase in leukotriene synthesis essential in atherosclerosis pathogenesis. Aim The aim of this study is to investigate the effect of “selected” genetic variants within the leukotriene (LT) pathway and other variants on the development of CAD. Methods CAD was detected by cardiac catheterization. Logistic regression was performed to investigate the association of smoking and selected susceptibility variants in the LT pathway including ALOX5AP, LTA4H, LTC4S, PON1, and LTA as well as CYP1A1 on CAD risk while controlling for age, gender, BMI, family history, diabetes, hyperlipidemia, and hypertension. Results rs4769874 (ALOX5AP), rs854560 (PON1), and rs4646903 (CYP1A1 MspI polymorphism) are significantly associated with an increased risk of CAD with respective odds ratios of 1.53703, 1.67710, and 1.35520; the genetic variant rs9579646 (ALOX5AP) is significantly associated with a decreased risk of CAD (OR 0.76163). Moreover, a significant smoking-gene interaction is determined with CYP1A1 MspI polymorphism rs4646903 and is associated with a decreased risk of CAD in current smokers (OR 0.52137). Conclusion This study provides further evidence that genetic variation of the LT pathway, PON1, and CYP1A1 can modulate the atherogenic processes and eventually increase the risk of CAD in our study population. Moreover, it also shows the effect of smoking-gene interaction on CAD risk, where the CYP1A1 MspI polymorphism revealed a decreased risk in current smokers.PublishedN/A2016-03-17T09:19:37Z2016-03-17T09:19:37Z20152016-03-17Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1023-3830http://hdl.handle.net/10725/3347http://dx.doi.org/10.1007/s00011-015-0821-1Merhi, M., Demirdjian, S., Hariri, E., Sabbah, N., Youhanna, S., Ghassibe-Sabbagh, M., ... & Chammas, E. (2015). Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk. Inflammation Research, 64(6), 415-422.http://link.springer.com/article/10.1007/s00011-015-0821-1enInflammation Researchinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/33472020-02-20T11:07:41Z
spellingShingle Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
Merhi, Mahmoud
status_str publishedVersion
title Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
title_full Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
title_fullStr Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
title_full_unstemmed Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
title_short Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
title_sort Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
url http://hdl.handle.net/10725/3347
http://dx.doi.org/10.1007/s00011-015-0821-1
http://link.springer.com/article/10.1007/s00011-015-0821-1